Pay in 4 interest-free payments of $22.50 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
ClH/c1-3-18-8-11-21(12-9-18)31-16-19-6-4-5-7-22(19)26(30)29-20-10-13-25-23(15-20)24(27)14-17(2)28-25
Formula: C25H34F2O5
3-b)furan-2(3H)-one
SB-269970 has been used to target the 5-HT7 receptor in the study of schizophrenia-like cognitive deficits
Etofibrate enhances or decreases plasma glycerol levels depending on both the dose and the time after treatment
GDC-0980 - CAS# 1032754-93-0 Size:Solid 2 mg ClH/c1-3-18-8-11-21(12-9-18)31-16-19-6-4-5-7-22(19)26(30)29-20-10-13-25-23(15-20)24(27)14-17(2)28-25Apitolisib, also known as GDC 0980 and RG7422; or GNE390, is a dual PI3 kinase mTOR inhibitor, is also a n orally available agent targeting phosphatidylinositol 3 kinase (PI3K) and mammalian target of rapamycin (mTOR) kinase in the PI3K mTOR signaling pathway, with potential antineoplastic activity. PI3K mTOR kinase inhibitor GDC 0980 inhibits both PI3K kinase and mTOR kinase, which may result in tumor cell apoptosis and growth inhibition of cancer
US$ 27.95
US$ 31.00
US$ 36.95
US$ 42.00